⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11098163 | 0.70 | — | — | |
| SCHEMBL7158952 | 0.70 | — | — | |
| SCHEMBL181825 | 0.70 | — | — | |
| SCHEMBL3189499 | 0.67 | CA1 (0.33) | — | |
| SCHEMBL2274959 | 0.67 | — | — | |
| Bicarbonate SCHEMBL5502655 | 0.67 | — | — | |
| SCHEMBL130293 | 0.65 | — | — | |
| SCHEMBL2910940 | 0.65 | — | — | |
| SCHEMBL4562572 | 0.65 | — | — | |
| SCHEMBL8180839 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111934016-B | Non-aqueous electrolyte of lithium ion battery and lithium ion battery containing non-aqueous electrolyte | 珠海市赛纬电子材料股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-111934016-A | Non-aqueous electrolyte of lithium ion battery and lithium ion battery containing non-aqueous electrolyte | 珠海市赛纬电子材料股份有限公司 | 2020-11-13 | — | — | CN | claimed |
| EP-2209776-A1 | AMINOACYL PRODRUGS AS AN ACTIVE PHARMACEUTICAL INGREDIENT FOR THROMBOEMBOLIC DISORDER | Bayer Schering Pharma AG (DE) | 2010-07-28 | — | — | EP | claimed |
| EP-2084154-A1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR TREATMENT OF THROMBOEMBOLIC DISORDERS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-08-05 | — | — | EP | claimed |
| EP-1471921-B1 | COUNTERACTING BIOPROSTHETIC CALCIFICATION | PHILADELPHIA CHILDREN HOSPITAL (US) | 2009-03-11 | — | — | EP | claimed |
| EP-1268561-B1 | METHOD FOR PRODUCING POLYMERS | BASF SE (DE) | 2009-01-28 | — | — | EP | claimed |
| WO-2009007026-A1 | AMINOACYL PRODRUGS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-01-15 | — | — | WO | claimed |
| WO-2008022786-A1 | AMINOACYL PRODRUG DERIVATIVES AND MEDICAMENTS FOR TREATMENT OF THROMBOEMBOLIC DISORDERS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-02-28 | — | — | WO | claimed |
| US-6809165-B2 | Method for producing polymers | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-26 | — | — | US | claimed |
| US-20030073793-A1 | Method for producing polymers | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-17 | — | — | US | claimed |
| EP-3643713-B1 | HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF | IOMX THERAPEUTICS AG (DE) | 2025-07-30 | — | — | EP | disclosed |
| US-20250101015-A1 | HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF | IOMX THERAPEUTICS AG (DE) | 2025-03-27 | — | — | US | disclosed |
| US-20250084076-A1 | HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF | IOMX THERAPEUTICS AG (DE) | 2025-03-13 | — | — | US | disclosed |
| US-12172993-B2 | Heterocyclic kinase inhibitors and uses thereof | IOMX THERAPEUTICS AG (DE) | 2024-12-24 | — | — | US | disclosed |
| CN-117015526-A | Aryl sulfonamides as orexin receptor agonists | 研究三角协会 | 2023-11-07 | — | — | CN | disclosed |
| US-5686382-A | Thermal recording structure and method | RICOH COMPANY, LTD. (JP) | 1997-11-11 | — | — | US | disclosed |
| CN-1132505-A | Amidine derivatives with nitric oxide synthetase activities | ASTERA CO (SE) | 1996-10-02 | — | — | CN | disclosed |
| US-5169992-A | Bisphenol A production using acidic clay catalysts | TEXACO CHEMICAL COMPANY (US) | 1992-12-08 | — | — | US | disclosed |
| US-4618669-A | FOR CELL INJURIES CAUSED BY ACTIVE OXYGEN METABOLITES | A. NATTERMANN & CIE GMBH (DE) | 1986-10-21 | — | — | US | disclosed |
| EP-0004711-A2 | Process for the cross-linking of polymers | Vulnax International Limited (GB) | 1979-10-17 | — | — | EP | disclosed |